Cover extends to the global exposures of US-domiciled companies, with 30 traditional and alternative capital providers pricing each placement individually.
The Amwins-Dragoneer-KKR consortium is finalising documentation and financing for its proposed A$7.7bn (US$5.5bn) acquisition of Steadfast after entering the final stages of due diligence.